Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,420.00    4.00 (0.28%)
Bid:
1,426.00
Ask:
1,430.00
Spread: 4.00 (0.281%)
Market Cap: £486.17m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Dividend Timetable

21 Sep 2021 17:58

RNS Number : 5194M
Craneware plc
21 September 2021
 

 

Craneware plc

("Craneware" or the "Company" or the "Group")

 

Dividend Timetable

 

 

21 September 2021 - Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces an amendment to the dividend timetable announced in its Final Results on 21 September 2021.

 

The revised dividend timetable is as follows:

 

 

Ex-dividend date

25 November 2021

Record date

26 November 2021

Dividend payment date

21 December 2021

 

The final dividend of 15.5p per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who register to do so by the close of business on 26 November 2021. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 26 November 2021. The final dividend referred to within the Final Results announcement in US dollars of 21.47 cents is given as an example only using the Balance Sheet date exchange rate of $1.3853/£1 and may differ from that finally announced

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Robyn Fisher, Joe Pederzolli

craneware@almapr.co.uk

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, George Sellar, Andrew Clark

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Jack Botros, Alix Mecklenburg-Solodkoff

 

 

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor financial and operational performance so they can continue to drive better outcomes for the communities they serve. Craneware's Trisus platform combines revenue integrity, cost management and decision enablement into a single SaaS-based platform. Our flagship solution, Chargemaster Toolkit®, continually earns KLAS recognition in the Revenue Cycle - Chargemaster Management category and is part of our value cycle management suite, which includes charge capture, strategic pricing, 340B compliance, claims analytics, patient engagement, revenue recovery and retention, and cost and margin intelligence solutions.

 

Learn more at craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUAVNRANUKUAR
Date   Source Headline
2nd Jun 20117:00 amRNSInvestor and Analyst Presentation
2nd Jun 20117:00 amRNSCraneware InSight Contract Win
31st May 201112:24 pmRNSTotal Voting Rights
24th May 20117:00 amRNSDirector Declaration
28th Apr 20112:42 pmRNSTotal Voting Rights
27th Apr 201112:25 pmRNSBlocklisting Interim Review
27th Apr 201110:02 amRNSHolding(s) in Company
19th Apr 20115:28 pmRNSHolding(s) in Company
8th Apr 20114:18 pmRNSHolding(s) in Company
7th Apr 20114:49 pmRNSHolding(s) in Company
7th Apr 20113:52 pmRNSBlocklisting Application
7th Apr 20118:53 amRNSHolding(s) in Company
5th Apr 20112:11 pmRNSDirector Shareholding & Issue of Equity
1st Apr 20115:27 pmRNSAdditional Listing
31st Mar 20115:51 pmRNSTotal Voting Rights
25th Mar 20114:27 pmRNSHolding(s) in Company
25th Mar 20113:45 pmRNSDividend Currency Election
24th Mar 20117:00 amRNSAdditional Listing
17th Mar 20115:19 pmRNSDirector/PDMR Shareholding
15th Mar 201111:32 amRNSAdditional Listing
10th Mar 20115:27 pmRNSAdditional Listing
10th Mar 20115:22 pmRNSHolding(s) in Company
10th Mar 20115:18 pmRNSHolding(s) in Company
2nd Mar 20117:00 amRNSDirector & PDMR Shareholding
28th Feb 20114:31 pmRNSAdditional Listing
28th Feb 20113:46 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSHalf Yearly Report
18th Feb 20117:00 amRNSAcquisition of ClaimTrust
28th Jan 20118:26 amRNSHolding(s) in Company
25th Jan 20117:00 amRNSTrading Update & Notice of Results
21st Dec 20104:38 pmRNSAdviser - Change of Name
12th Nov 20108:19 amRNSDividend Currency Election
9th Nov 20102:34 pmRNSHolding(s) in Company
9th Nov 20102:22 pmRNSHolding(s) in Company
2nd Nov 20107:00 amRNSAGM Statement
19th Oct 20107:10 amRNSBlocklisting Interim Review
19th Oct 20107:00 amRNSPosting of Annual Report and Accounts
8th Oct 201012:44 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSContract Win for Supplies ChargeLink
22nd Sep 20107:00 amRNSHolding(s) in Company
9th Sep 20102:47 pmRNSDirector/PDMR Shareholding
8th Sep 20107:00 amRNSDirector/PDMR Shareholding
6th Sep 20107:00 amRNSFinal Results
10th Aug 20107:00 amRNSNotice of Final Results
14th Jul 20107:00 amRNSTrading Update
9th Jul 20107:00 amRNSLaunch of ADR Programme
22nd Apr 20104:08 pmRNSHolding(s) in Company-Amendment
22nd Apr 20102:27 pmRNSHolding(s) in Company
21st Apr 20103:41 pmRNSDirectors Shareholding
21st Apr 20107:00 amRNSReseller Agreement with Premier

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.